Cite

HARVARD Citation

    Santella, C. et al. (2022). Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease. Inflammatory bowel diseases. 28 (2), pp. 176-182. [Online]. 
  
Back to record